{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:03:45Z","timestamp":1761419025953},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12890-016-0229-x","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T08:15:15Z","timestamp":1463559315000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat"],"prefix":"10.1186","volume":"16","author":[{"given":"David S.","family":"Poch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"issue":"25 suppl D","key":"229_CR1","doi-asserted-by":"crossref","first-page":"42D","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl D):42D\u201350D.","journal-title":"J Am Coll Cardiol."},{"issue":"25 suppl D","key":"229_CR2","doi-asserted-by":"crossref","first-page":"34D","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl D):34D\u201341D.","journal-title":"J Am Coll Cardiol"},{"issue":"25 suppl D","key":"229_CR3","doi-asserted-by":"crossref","first-page":"4D","DOI":"10.1016\/j.jacc.2013.10.025","volume":"62","author":"RM Tuder","year":"2013","unstructured":"Tuder RM, Archer SL, Dorfm\u00fcller P, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl D):4D\u201312D.","journal-title":"J Am Coll Cardiol."},{"issue":"25 suppl D","key":"229_CR4","doi-asserted-by":"crossref","first-page":"73D","DOI":"10.1016\/j.jacc.2013.10.034","volume":"62","author":"VV McLaughlin","year":"2013","unstructured":"McLaughlin VV, McGoon MD. Treatment goals of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl D):73D\u201381D.","journal-title":"J Am Coll Cardiol."},{"issue":"25 suppl D","key":"229_CR5","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1016\/j.jacc.2013.10.031","volume":"62","author":"N Gali\u00e8","year":"2013","unstructured":"Gali\u00e8 N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25 suppl D):60D\u201372D.","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"229_CR6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","volume":"379","author":"N Galie\u2019","year":"2015","unstructured":"Galie\u2019 N, Barbera JA, Frost A, et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. New Engl J Med. 2015;379(9):834\u201344.","journal-title":"New Engl J Med"},{"key":"229_CR7","doi-asserted-by":"crossref","unstructured":"Humbert M, Vachiery J-L, Gibbs S, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2015:doi: 10.1093\/eurheartj\/ehv317 .","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"229_CR8","doi-asserted-by":"crossref","unstructured":"Humbert M, Ghofrani H-A. The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax. 2016;71:73-83.","DOI":"10.1136\/thoraxjnl-2015-207170"},{"key":"229_CR9","unstructured":"Adempas\u00ae [full prescribing information]. Whippany: Bayer HealthCare Pharmaceuticals Inc September; 2014."},{"key":"229_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","volume":"146","author":"DB Taichman","year":"2014","unstructured":"Taichman DB, Ornelas J, Chung L, et al. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guidelines and expert panel report. CHEST. 2014;146:449\u201375.","journal-title":"CHEST."},{"key":"229_CR11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"H-A Ghofrani","year":"2013","unstructured":"Ghofrani H-A, Galie N, Grimminger F, et al. Riociguat for the treatment of pulmonary arterial hypertension. New Engl J Med. 2013;369:330\u201340.","journal-title":"New Engl J Med."},{"key":"229_CR12","unstructured":"Adempas (riociguat) tablets [package insert]. Whippany: Bayer HealthCare Pharmaceuticals Inc; 2014."},{"key":"229_CR13","unstructured":"Bayer HealthCare. Riociguat clinical effects studied in patients with insufficient treatment response to phosphodiesterase-5 inhibitor (RESPITE). In: ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02007629 . Accessed 10 May 2016."},{"key":"229_CR14","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","volume":"123","author":"J-P Stasch","year":"2011","unstructured":"Stasch J-P, Pacher P, Evgenov OV. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation. 2011;123:2263\u201373.","journal-title":"Circulation."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-016-0229-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:52:48Z","timestamp":1498312368000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-016-0229-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1186\/s12890-016-0229-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]},"article-number":"82"}}